Kumaran, Binoy
Targett, Darren
Watson, Tim
Article History
Received: 28 April 2023
Accepted: 1 August 2024
First Online: 14 August 2024
Declarations
:
: Not applicable.
: The first author (BK) declares no competing interests. DT is an independent expert acting as a statistical consultant for Actegy Limited for this study (funder of the trial and manufacturer of Revitive<sup>®</sup>). TW has expert consultancy contract with Actegy Limited, which is unrelated to this study.
: This study was approved by the University of Hertfordshire Health, Science, Engineering and Technology Ethics Committee with Delegated Authority (HSETECDA). The study was conducted conforming with all required local and international medical device regulations. All experiments on humans were performed in accordance with relevant guidelines and regulations (such as the Declaration of Helsinki). Informed consent was received from all participants prior to the start of the study.